Researcher
Frank Claessens
- Disciplines:Endocrinology, Structural biology, Molecular and cell biology not elsewhere classified, Cancer biology, Urology and nephrology not elsewhere classified
Affiliations
- Laboratory of Molecular Endocrinology (Division)
Responsible
From1 Jan 2012 → Today - Laboratory of Molecular Endocrinology (Division)
Member
From1 Oct 2007 → Today - Faculty of Medicine (Faculty)
Member
From1 Oct 2000 → 31 Dec 2002
Projects
1 - 10 of 36
- Free steroid hormones in health and disease (FRESH-HD)From23 Jan 2024 → TodayFunding: Own budget, for example: patrimony, inscription fees, gifts
- Cooperativity between the androgen receptor and forkhead box A1 transcription factorFrom7 Aug 2023 → TodayFunding: Own budget, for example: patrimony, inscription fees, gifts
- New therapeutic targets in the dimerization modes that drive androgen receptor functioningFrom1 Oct 2022 → TodayFunding: Own budget, for example: patrimony, inscription fees, gifts
- New therapeutic targets in the dimerization modes that drive androgen receptor functioningFrom1 Jan 2022 → TodayFunding: FWO research project (including WEAVE projects)
- Peroxisomes and the Malignant Potential of Prostate Cancer Cells.From17 Jun 2021 → TodayFunding: Own budget, for example: patrimony, inscription fees, gifts
- TISSUE-SPECIFIC MODULATION OF GLUCOCORTICOID EFFECTS BY ANDROGENSFrom26 Oct 2020 → TodayFunding: Own budget, for example: patrimony, inscription fees, gifts
- Tissue specific modulation of the effects of glucocorticoids by androgens and the androgen receptor: revealing the mechanisms of cross talFrom1 Oct 2020 → TodayFunding: BOF - doctoral mandates
- Classical and non-classical actions of androgens and their receptorFrom1 Oct 2019 → 30 Sep 2023Funding: IOF - technology concept exploration, BOF - projects
- The role of androgens in chronic kidney desease: a missing link in the calcification paradox?From1 Aug 2019 → 31 Oct 2023Funding: FWO fellowships
- Structural Biology of the Human Androgen Receptor for next generation drug designFrom12 Mar 2018 → 12 Mar 2022Funding: Own budget, for example: patrimony, inscription fees, gifts
Publications
181 - 190 of 223
- Musculoskeletal Frailty: A Geriatric Syndrome at the Core of Fracture Occurrence in Older Age(2012)
Authors: Evelien Gielen, Sabine Verschueren, Frank Claessens, Michaël Laurent, Koen Milisen, Jos Tournoy, Marian Dejaeger, Dirk Vanderschueren, Steven Boonen
Pages: 161 - 177 - Variations in the exome of the LNCaP prostate cancer cell line(2012)
Authors: Lien Spans, Zeynep Kalender Atak, Evelyne Lerut, Stein Aerts, Frank Claessens
Pages: 1317 - 27 - Evidence for DBD-LBD communications in the androgen receptor(2012)
Authors: Christine Helsen, Vanessa Dubois, Annelien Verfaillie, Renée Vancraenenbroeck, Marc De Maeyer, Frank Claessens
Pages: 3033 - 3043 - Evidence for DNA-Binding Domain-Ligand-Binding Domain Communications in the Androgen Receptor(2012)
Authors: Christine Helsen, Vanessa Dubois, Annelien Verfaillie, Marc De Maeyer, Frank Claessens
Pages: 3033 - 3043 - Sarcopenia and bone mineral density in European men(2012)
Authors: Evelien Gielen, Sabine Verschueren, Terence O'Neill, Stephen Pye, Judith Adams, Kate Ward, Frederick Wu, Pawel Szulc, Michaël Laurent, Frank Claessens, et al.
Pages: S556 - S556 - Time to onset of antifracture efficacy and year-by-year persistence of effect of zoledronic acid in women with osteoporosis(2012)
Authors: Steven Boonen, Frank Claessens, Dirk Vanderschueren
Pages: 1487 - 1493 - The hinge region in androgen receptor control(2012)
Authors: Liesbeth Clinckemalie, Dirk Vanderschueren, Steven Boonen, Frank Claessens
Pages: 1 - 8 - Het nut van 5-alfa-reductase-inhibitoren bij patiënten onder actieve opvolging voor prostaatkanker met een laag risico?(2012)
Authors: Michaël Laurent, Frank Claessens, Steven Joniau
Pages: 60 - 61 - Targeted disruption of androgen receptor in mouse osteocytes: The androgen receptor in osteocytes is important for the maintenance of bone structure in males(2012)
Authors: Mieke Sinnesael, Frank Claessens, Steven Boonen, Dirk Vanderschueren
Pages: S60 - S60 - Identification and Characterization of MEL-3, a Novel AR Antagonist That Suppresses Prostate Cancer Cell Growth(2012)
Authors: Christine Helsen, Arnaud Marchand, Patrick Chaltin, Sebastian Munck, Arnout Voet, Mieke Verstuyf, Frank Claessens
Pages: 1257 - 1268